Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1488.7000 -6.10 (-0.41%)
NSE May 29, 2025 12:02 PM
Volume: 76,588
 

logo
Ipca Laboratories Ltd.
30 Sep 2024
1488.70
-0.41%
buy
by Sharekhan
Target: 1734 | Target met
Sharekhan
Ipca’s board would discuss the strategic integration of Bayshore Pharmaceuticals’ generics business into Unichem Pharma (USA) Inc on September 30, 2024.
 
Ipca Laboratories Ltd. has an average target of 1815.00 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended
Market trades flat, Natco Pharma's net profit grows 5.3% YoY to Rs 406.6 crore in Q4
Trendlyne Marketwatch | 29 May 2025, 12:03PM
Capital markets consider India as US turns volatile | Screener: Stocks with high debt and interest payments
The Baseline | 28 May 2025, 11:08PM
IPCA Labs’ domestic formulations business to drive growth
| 05 Jul 2021